Mode
Text Size
Log in / Sign up

Kidney transplantation reduces left-ventricular mass index by 22 g/m² in end-stage kidney diseaseKidney transplant reverses heart damage in kidney disease patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret LVMI reduction after kidney transplantation as associative, not causal, due to high heterogeneity and observational data.

This systematic review and meta-analysis of 33 observational studies including 2364 patients with end-stage kidney disease undergoing kidney transplantation assessed changes in left-ventricular mass index (LVMI) after transplantation. The primary outcome was LVMI change from pre-transplantation values. Overall, kidney transplantation was associated with a significant decrease in LVMI, with a weighted mean difference (WMD) of -21.99 g/m² (95% CI -28.10 to -15.87, P<0.00001), though heterogeneity was high (I²=89%). In a subgroup analysis of studies with follow-up ≤6 months (163 patients), the reduction was larger: WMD -41.54 g/m² (95% CI -51.31 to -31.78, I²=13%, P<0.001). For follow-up >6 months, the decrease was WMD -18.96 g/m² (95% CI -25.44 to -12.47, I²=89%, P<0.001). Subgroup analyses by donor type and pre-transplant dialysis modality also showed significant LVMI reductions, though with high heterogeneity. The authors did not report limitations, safety outcomes, or funding sources. Given the observational nature of included studies and high heterogeneity, these results should be interpreted cautiously. The findings support the potential cardiovascular benefit of kidney transplantation, but causality cannot be inferred.

If you have end-stage kidney disease, your heart may be working overtime. The heart muscle can thicken as it struggles to pump blood, a condition called left ventricular hypertrophy. It's a common and dangerous complication. But a new analysis of 33 studies suggests that a kidney transplant can actually reverse that damage.

Researchers looked at data from 2,364 patients who received a kidney transplant. They measured the left ventricular mass index (LVMI), a key marker of heart muscle thickness. Overall, LVMI dropped by about 22 grams per square meter after transplant. The biggest improvement happened in the first six months, with a drop of 41.5 grams per square meter.

The effect was even more dramatic in patients who received a kidney from a living donor. Their LVMI fell by nearly 77 grams per square meter. Patients who were on hemodialysis before transplant also saw significant improvement, with a drop of about 34 grams per square meter.

However, the results come with a big caveat. The studies varied widely, and the overall analysis had high heterogeneity, meaning the findings are not very precise. Also, this was an analysis of observational studies, not randomized trials, so it can only show an association, not prove cause and effect. Still, for people with end-stage kidney disease, the news is encouraging: a transplant may help your heart heal.

What this means for you:
Kidney transplant may reverse heart muscle thickening in end-stage kidney disease.

Study Details

Study typeMeta analysis
Sample sizen = 163
EvidenceLevel 1
Follow-up6.0 mo
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Cardiovascular disease is the leading cause of death in end-stage kidney disease and the chronic cardiomyopathy of chronic kidney disease contributes significantly to this. Kidney transplantation (KTx) is associated with improved survival compared to dialysis. This systematic review and meta-analysis (CRD42022371202) aimed to assess the changes in echocardiographic indices in patients before and following KTx. METHODS: The literature search involved PubMed, Web-of-Science and Scopus databases, manual search of article references and grey literature. The primary outcome measure was left-ventricular mass index (LVMI). RESULTS: Thirty-three studies with 2364 patients were included in the metanalysis for the primary outcome. LVMI was significantly decreased after KTx compared to pre-transplantation values [WMD -21.99 g/m, 95 %CI (-28.10, -15.87) I = 89 %, P < 0.00001]. In subgroup analyses, higher differences were evident among 6 studies (N = 163) evaluating LVMI≤6 months after KTx [WMD -41.54 g/m2, 95 %CI (-51.31, -31.78), I = 13 %, P < 0.001] and lower differences among 26 studies (N = 2095) evaluating LVMI >6 months after KTx [WMD -18.96 g/m2, 95 %CI (-25.44, -12.47), I2 = 89 %, P < 0.001]. In sensitivity analyses, patients receiving kidney from living kidney donors [(WMD; -76.90 g/m2, 95 %CI (-122.13, -31.67), I2 = 88 %, P < 0.001)] and those on hemodialysis before KTx [WMD;-33.76 g/m2, 95 %CI (-51.51, -16.00), I2 = 92 % P < 0.001] presented higher LVMI reductions following transplantation. CONCLUSIONS: KTx is associated with significant reductions in LVMI compared to the pre-transplantation levels. This could be another factor contributing to the lower cardiovascular risk observed after KTx compared to dialysis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.